Ameriprise
ZYME icon

Ameriprise’s Zymeworks ZYME Stock Holding History

Ameriprise’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.86M Sell
74,222
-38,919
-34% -$921K ﹤0.01% 2996
2025
Q4 		$2.98M Buy
113,141
+37,213
+49% +$812K ﹤0.01% 2784
2025
Q3 		$1.3M Buy
+75,928
New +$1.09M ﹤0.01% 3232
2025
Q1 		– Sell
-121,526
Closed -$1.78M – 4164
2024
Q4 		$1.78M Sell
121,526
-15,800
-12% -$221K ﹤0.01% 2990
2024
Q3 		$1.72M Hold
137,326
– – ﹤0.01% 2987
2024
Q2 		$1.17M Sell
137,326
-4,467
-3% -$39.8K ﹤0.01% 3097
2024
Q1 		$1.49M Buy
141,793
+18,867
+15% +$210K ﹤0.01% 3008
2023
Q4 		$1.28M Buy
+122,926
New +$980K ﹤0.01% 3091

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ameriprise's ZYME Position: Q1 2026 in Review

Ameriprise reduced its Zymeworks (ZYME) stake by 34% in Q1 2026, selling an estimated $921K and leaving 74,222 shares worth $1.86M. The position accounts for ﹤0.01% of the portfolio, ranked #2996.

Ameriprise first reported a position in ZYME in Q4 2023 and has held it in 8 quarters since. The position peaked at $2.98M in Q4 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Ameriprise held 74,222 shares of Zymeworks worth $1.86M as of Q1 2026.
  • Ameriprise sold 38,919 Zymeworks shares in Q1 2026, an estimated $921K.
  • Zymeworks made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #2996 holding.
  • Ameriprise first reported a position in Zymeworks in Q4 2023 and has held it in 8 quarters since.
  • Ameriprise's Zymeworks position peaked at $2.98M in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.